4/A//SEC Filing
Khosrovi Behzad 4/A
Accession 0001437749-10-004517
CIK 0001389545other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 2:18 PM ET
Size
5.9 KB
Accession
0001437749-10-004517
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2010-11-15+40,000→ 364,200 totalExercise: $1.89From: 2011-11-15Exp: 2020-11-14→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Original Form 4 filed on Nobember 15, 2010. This amendment is filed to correct the exercise price from $1.85 to 1.885 per share.
- [F2]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the grant date from November 12, 2010 to November 15, 2010, the date the last signature to the Board Written Consent granting the options was received by the Company.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 2:18 PM ET
- Size
- 5.9 KB